ArticleJournal of imaging2021
Per-COVID-19: A Benchmark Dataset for COVID-19 Percentage Estimation from CT-Scans.
Article in Journal of imaging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- COVID-19 Infection Percentage Estimation from Computed Tomography Scans: Results and Insights from the International Per-COVID-19 Challenge.Sensors (Basel, Switzerland) · 2024Review
- EffViT-COVID: A dual-path network for COVID-19 percentage estimation.Expert systems with applications · 2023Article
- Comparison of Convolutional Neural Networks and Transformers for the Classification of Images of COVID-19, Pneumonia and Healthy Individuals as Observed with Computed Tomography.Journal of imaging · 2022Article
- Determination of the Severity and Percentage of COVID-19 Infection through a Hierarchical Deep Learning System.Journal of personalized medicine · 2022Article
- Recognition of COVID-19 from CT Scans Using Two-Stage Deep-Learning-Based Approach: CNR-IEMN.Sensors (Basel, Switzerland) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
COVID-19 infection recognition is a very important step in the fight against the COVID-19 pandemic. In fact, many methods have been used to recognize COVID-19 infection including Reverse Transcription Polymerase Chain Reaction (RT-PCR), X-ray scan, and Computed Tomography scan (CT- scan). In addition to the recognition of the COVID-19 infection, CT scans can provide more important information about the evolution of this disease and its severity. With the extensive number of COVID-19 infections, estimating the COVID-19 percentage can help the intensive care to free up the resuscitation beds for the critical cases and follow other protocol for less severity cases. In this paper, we introduce COVID-19 percentage estimation dataset from CT-scans, where the labeling process was accomplished by two expert radiologists. Moreover, we evaluate the performance of three Convolutional Neural Network (CNN) architectures: ResneXt-50, Densenet-161, and Inception-v3. For the three CNN architectures, we use two loss functions: MSE and Dynamic Huber. In addition, two pretrained scenarios are investigated (ImageNet pretrained models and pretrained models using X-ray data). The evaluated approaches achieved promising results on the estimation of COVID-19 infection. Inception-v3 using Dynamic Huber loss function and pretrained models using X-ray data achieved the best performance for slice-level results: 0.9365, 5.10, and 9.25 for Pearson Correlation coefficient (PC), Mean Absolute Error (MAE), and Root Mean Square Error (RMSE), respectively. On the other hand, the same approach achieved 0.9603, 4.01, and 6.79 for PCsubj, MAEsubj, and RMSEsubj, respectively, for subject-level results. These results prove that using CNN architectures can provide accurate and fast solution to estimate the COVID-19 infection percentage for monitoring the evolution of the patient state.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.